Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2021-02-12 2021-02-12
Drug Identification Number 02259354 02259354
Brand name TEVA-MIRTAZAPINE TEVA-MIRTAZAPINE
Common or Proper name MIRTAZAPINE 30MG TABS MIRTAZAPINE 30MG TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MIRTAZAPINE MIRTAZAPINE
Strength(s) 30MG 30MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size PP 30 PP 30
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-20 2021-01-20
Estimated end date
Actual end date 2021-02-05 2021-02-05
Shortage status Resolved Resolved
Company comments Item is discontinued Item is discontinued
Health Canada comments